Skip to Content
PDR_stacked_purple (002)
  • Drug Information

    Drug Information

    • Browse by Drug Name
  • Drug Communication
  • Resources

    Resources

    • mobilePDR®
    • PDR Drug Update Newsletters
    • PDR Update Newsletters
    • Patient Resources in Workflow
  • About Us
Contact Us

PDR Drug Updates

Get more information on PDR's monthly Drug Updates, including the latest in FDA news and drug labeling updates.

2026 eDrug Updates


  • January 2026: Reducing Vasomotor Symptoms in Menopause
  • February 2026: On-Demand Therapy for PSVT
  • March 2026: Integrating PCSK9 Inhibitors into LDL-C-Lowering Therapy
  • April 2026: Treating Motion Sickness in Adults
  • May 2026: Continued Growth in Oral Incretin-Based Therapy Options
  • June 2026: Helping Improve Survival in Pediatric Menkes Disease
  • July 2026: Breakthrough Treatment for Otoferlin-Related Hearing Loss
  • August 2026: Preventing COVID-19 After Exposure
  • September 2026: Promising New Management for Chronic Hepatitis Delta Virus
  • October 2026: Expanding Treatment Options for Dermatomyositis
  • November 2026: Maintaining Hematocrit Control in Polycythemia Vera

PDR_stacked_white
  • Drug Information
  • Resources
  • Careers
  • Drug Communication
  • FAQs
  • Report Adverse Events
Contact Us

U.S.-based MDs, DOs, NPs and PAs in full-time patient practice can register for free access to the Prescribers’ Digital Reference on PDR.net. PDR.net is to be used only as a reference aid, it is not intended to be a substitute for the exercise of professional judgement. You should confirm the information on the PDR.net site through independent sources and seek other professional guidance in all treatment and diagnosis decisions.

1-888-227-6469

© 2024 PDR, LLC. All rights reserved. | Terms of Service | California Residents | Supplemental Privacy Notice | Privacy Policy | Rules | ConnectiveRx